Publicacións en colaboración con investigadores/as de Hospital Alemão Oswaldo Cruz (22)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  2. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

2022

  1. Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults

    Human Vaccines and Immunotherapeutics, Vol. 18, Núm. 1

2021

  1. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

2020

  1. Repositioning of the global epicentre of non-optimal cholesterol

    Nature, Vol. 582, Núm. 7810, pp. 73-77

2019

  1. Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial

    Vaccine, Vol. 37, Núm. 35, pp. 4858-4863

  2. Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: Results from the Global Influenza Hospital Surveillance Network

    BMC Infectious Diseases, Vol. 19, Núm. 1

  3. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature

2017

  1. Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial

    Vaccine, Vol. 35, Núm. 16, pp. 2052-2059

  2. Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial

    Vaccine, Vol. 35, Núm. 28, pp. 3548-3557

2016

  1. A century of trends in adult human height

    eLife, Vol. 5

  2. Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Núm. 47, pp. E7535-E7544

  3. Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants

    The Lancet, Vol. 387, Núm. 10026, pp. 1377-1396

  4. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants

    The Lancet, Vol. 387, Núm. 10027

  5. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants

    The Lancet, Vol. 387, Núm. 10027, pp. 1513-1530

2014

  1. Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain

    AIDS Research and Human Retroviruses, Vol. 30, Núm. 9, pp. 856-862

2008

  1. Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: A HuGE-GSEC review

    Genetics in Medicine, Vol. 10, Núm. 6, pp. 369-384

1997

  1. Identification of Transcribed Sequences (ESTs) in the Trypanosoma cruzi Genome Project

    Memorias do Instituto Oswaldo Cruz, Vol. 92, Núm. 6, pp. 863-866